PharmaSources.com (http://www.PharmaSources.com/news) is the initiator of the original writers league in the pharmaceutical industry. Our goal is to provide users with up-to-date, professional and in-depth industry reports on a daily basis, to achieve effective sharing of information among pharmaceutical professionals and together to witness the development of pharmaceutical industry.
What we can provide:
An opportunity to become KOL in the pharmaceutical industry
First release and exclusive rights for PharmaSources.com
If you are an expert in Pharma, if you have passions for writing in spare time, join us to share your insights into the hot news, market analysis, research and development of the pharmaceutical industry!
The marketing application (acceptance No.: CYHS1900381) of Chia Tai Tianqing’s Class 4 generic drug has recently changed to the “Under approval” status, and the drug is expected to be approved for marketing this month ...
Junshi Biosciences has recently announced its 2020 annual performance preview, according to which, it achieved operating income of RMB1.595 billion, up 105.77% year on year, mainly thanks to the sales revenue growth of its anti-PD-1 drug.